Eli Lilly Reports Medication Slows Alzheimer’s Decline

According to an article via South Bend Tribune, “Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer’s if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a...

ICYMI: FDA and Manufacturers Map Out PDUFA Reform Priorities

According to an article via BioPharmInternational.com, “A year-long process reauthorizing the Prescription Drug User Fee Act (PDUFA) was launched July 15, 2015 with a public meeting, setting the stage for monthly discussions with industry beginning this fall and...

Pfizer Set to Acquire Hospira

Pfizer announced in a press release that “they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 a share...

House Bill Would Speed Drug Approvals, Boost Research

In a recent article from the New York Times, drug approvals could have a faster turnaround if a new bill passes through the House of Representatives. According to the article, “Urged on by the medical industry and patients’ groups, the House overwhelmingly...